Tomoyuki Urata
Tomoyuki Urata publishes mostly in Pulmonary and Respiratory Medicine, Epidemiology and Oncology, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Fungal Infections and Studies.
- World rank
- #6,689,306 of 7,710,434 ranked researchers
- Rank in United States
- #1,545,919 of 1,627,098
- Works
- 19
- Citations
- 211
- Citations per work
- 11.1
What does Tomoyuki Urata research?
Tomoyuki Urata's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1370.6%
- Medicine1370.6%
- Everything else423.5%
- Life Sciences15.9%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Epidemiology16% of their works
- 3Oncology16% of their works
- 4Rheumatology8% of their works
- 5Cancer Research6% of their works
- 6Physiology4% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Inflammatory Myopathies and Dermatomyositis
- Cell Adhesion Molecules Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Which keywords describe Tomoyuki Urata's research?
The keywords of their largest research topics: Targeted Therapy, ALK Inhibitors, EGFR Mutations, Treatment, Cancer Genomics, Cell Adhesion, Cetuximab and Chemotherapy-Induced Peripheral Neuropathy.
- Taxanes
- Pneumocystis
- KRAS Mutations
- Inflammatory Myopathies
- Dermatomyositis
- Chemotherapy-Induced Peripheral Neuropathy
- Cell Adhesion
- Treatment
- ALK Inhibitors
- Targeted Therapy
- EGFR Mutations
- Cancer Genomics
- Cetuximab
- Cryptococcal Disease
- Histoplasmosis
- Integrins
- Mutational Signatures
- Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Targeted Therapy72 topics
- ALK Inhibitors51 topic
- EGFR Mutations51 topic
- Treatment42 topics
- Cancer Genomics21 topic
- Cell Adhesion21 topic
- Cetuximab21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Cryptococcal Disease21 topic
- Dermatomyositis21 topic
- Histoplasmosis21 topic
- Inflammatory Myopathies21 topic
- Integrins21 topic
- KRAS Mutations21 topic
- Mutational Signatures21 topic
- Pneumocystis21 topic
- Pneumonia21 topic
- Taxanes21 topic
Where does Tomoyuki Urata work?
Tomoyuki Urata's main affiliation in the publication record is CHI Health, United States.
How many publications and citations does Tomoyuki Urata have?
OpenAlex counts 19 works and 211 citations for Tomoyuki Urata, an h-index of 8, ranking #6,689,306 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tomoyuki Urata. Posts are plain text and can be reported.